Lecture 38 & 41 - Intro to Anti-Microbials + Cell Envelope Anti-Microbials Flashcards

(40 cards)

1
Q

Name the 2 Folate Anti-Metabolites

A

Sulfonamides

Trimethoprim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sulfonamide:
Common Agent
Mechanism

A

Common Agent: Sulfamethoxazol

Mechanism: Analogous structure to PABA.
Inhibition of Dihydropteroate Synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Trimethoprim:

Mechanism

A

Inhibition of DIhydrofolate Reductase

Bacteriostatic when used alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TMP-SMX

  • What is it?
  • Spectrum/Clinical uses?
  • Is it bacterostatic or bacterocidal
A

Combination of Trimpethoprime + Sulfamethoxazole (1:5 ratio)

Spectrum:
-GN (but NOT pseudomonas)
- GP: Staphylococci;
Most Enterococci are resistant

Uses: UTI, GI, Respiratory

Bactericidal with Excellent Bioavailbility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TMP-SMX: Adverse Events

Drug interactions

A
  • All abx: alteration of the micro-biota
  • Common: Rash, Nausea, Vom, HA
    Uncommon: Hyperkalemia, hepatitis, pancreatitis
    Rare: Steven’s Johnson, aplastic anemia, thrombocytopoenia,

Drug Interxn: Displaces warfarin and Pehytoi from Albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name the Classes of abx that are “DNA inhibitors”

A
  • Quinolones, Fluoroquinolones

- Nitrofurantoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Quinolones, Fluoroquinolones:
- Common Agents and their Mechanisms

  • Adverse Effects
  • Bactericidal or Static?
  • Resistance Mechanisms for Quinolones
A

Common Agents:

Ciprofloxacin - DNA Gyrase (topoisomerase II) inhibitor

Moxifloxacin
- Topo II and Topo IV Inhibitor

Stabilization of the Double Stranded DNA breaks – leading to chromosomal fragmentation

Adverse Effects: Overall quite well tolerated

  • Common: N, V, abd, HA, dizziness
  • Serious: Prolonged QT Syndrome

Bactericidal

Mutation to the Target: GryA, ParC
Plasmids, Efflux pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ciprofloxacin: Spectrum and Clinical uses

Moxifloxacin: Spectrum

A

Cipro Spectrum: GN, Atypicals
Clinical uses: UTIs

Moxi: GN, GP, anaerobic, atypicals
Poor penetration to the GU tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitrofurantoin -
Mechanism

Clinical Uses:

Adverse Effects:

A

Mechanism: Unknown damage to the DNA; also binds RNA and interfers with Translation

Clinical Uses: Exclusively Used for UTIs

Adverse Effects: Nausea, Pulmonary Fibrosis with prolonged use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What abx are considered RNA inhbitors?

A

Rifamycins: Rifampin, Rifabutin, Rifaximin

Fidaxomicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rifamycins -
Mechanism
Bacteriostatic or Cidal?
Adverse Effects?

A

Mechanism: Inhibition of RNA Polymerase

Bacteriostatic

GI: N, V, D, abd pain
Heme: Thrombocytopenia, anemia, hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spectrum In General:

Clinical Uses

What is different about Rifaximin

A

General: Broad Spectrum
- GP, GN, Mycobacterial

Clinical uses: Prophylaxis for N. meningitis, S. Aureus

Rifaximin: Not absorbed; only used GI (enteric) infections

Clinical uses: Traveler’s diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Fidaxomicin: 
Mechanism 
Adverse Effects 
What's unique about it? 
Spectrum
Clinical uses
A

Mechanism: Blocks RNA polymerase; prevents formation of DNA complex

Adverse effects: None

Unique: Non-absorbed;

Spectrum: C. DIff Only; No GNs

Clinical use: Use for C. Diff. Only if relapse after Vanc therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What Abx Classes Attack the Cell-Envelope?

A

Beta Lactams: PCN and derivatives, Cephalosporins, Carbapenams, Monobactams

Glyocopeptides

Cyclic Lipopeptides

Other (Polymyxins, bacitracin, fosfomycin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the General mechanism of Beta Lactam Agents

A

B-lactam ring
Resembles peptide
Mimics terminal D-ala-D-ala of peptidoglycan monomer (pentapeptide)
Penicillin binds to transpeptidases (PBPs) of bacterial cell – now these enzymes not available to from stabilizing cross-links
· Autolysins still break up cell wall – continual remodeling
· Weaker and weaker cell wall
Eventually leads to cell lysis from osmotic pressure – death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanisms of Resistance Against Beta Lactam Agents?

A

B-lactamases (inactivate it and break it)
· Enzymes that hydrolyze the beta-lactam ring
Penicillinases, cephalosporinases, carbepenemases
Extended-spectrum beta-lactamases (ESBL)

Modified PBP’s
- MRSA, encoded by mecA gene

Decreased permeability/porins 
· Avoid it – don’t let it in 
Efflux pumps (MDR)
· Avoid it – pump it out
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PCN (General)

  • Bactericidal or static?
  • Common Adverse Effects:
A
  • Bactericidal
  • Adverse Effects:
    hypersensitivity: Rash, hives, anaphylaxis, serum sickness, cytopenias, nephritis
  • Seizures are high doses
18
Q

PCN (G)
- Spectrum

  • Clinical uses
A

Gram negative: GN cocci only

Gram positive: cocci/anaerobes (good if resistance not present)

Infections caused by Streptococci
Dental abscesses/human bites (GP anaerobe)
Syphilis
IV Only

19
Q

PCN - SemiSynthetics:
-Common Agents

Mechanism:

Common Resistances: what gene causes this?

Spectrum

A

Nafcillin (IV)
Dicloxacillin (PO)
(Methicillin)

Penicillinase-resistant penicillins (pre-MRSA)
· Bulky “R” Group – can’t fit into many b-lactamases
· Still maintain b-lactam ring

Resistance due to altered PBP (new protein PBP2a) encoded by mecA gene
· MRSA

Spectrum:
Gram-positive ONLY
Cannot penetrate Gram-negative (thick OM)

20
Q

Amino-PCNs
- Common agents

  • Mechanistic change
  • Spectrum of Activity
A

Ampicillin (IV)
Amoxicillin (PO)

R-group more polar, allows penetration through some Gram-negative porins

GP: Strep and cocci
Some Gram-negative porins:
· H. flu, E. coli
· NOT Pseudomonas

21
Q

Anti-Pseudomonal penicillins

  • Common Agents
  • Resistances
  • Spectrum of activity:
A
  • Piperacillin (used with tazobactam)
  • Uses is limited by penicillinases
    Never used alone

Spectrum:
GP, but not MRSA
Some GN – Pseudomonas

22
Q

Beta Lactamase Inhibitors:

  • what do they do?
  • Common agents
  • Spectrum
A
  • Extend the activity of penicillins and overcome much of resistance
  • Ampicillin – sulbactam
    · Adds S. aureus (not MRSA), B-lactamase-producing GN and anaerobes
    Amoxicillin – clavulanic acid (augmentin)
    · Similar, but PO

Piperacillin-tazobactam
· Adds S. aureus (not MRSA), B-lactamase producing GN and anaerobes (including Pseudomonas)
· Becomes broad spectrum antibiotic

23
Q

Beta Lactam: Cephalosporins

  • Common Adverse Effects
  • General Spectrum
A

Common Adverse Effects:
Well tolerated; Some cross re-activity with PCN allergy

Spectrum:
Most have some GP coverage
Gram Negative coverage increases with generations 1 through 4

24
Q

First Generation Cephalosporins

  • Common agents
  • Spectrum
  • Clinical uses
A

Cefazolin (IV)
Cephalexin (PO)

Good Gram + activity

Surgical prophylaxis – prevent infections caused by pathogens at site surgery (i.e. common Strep/Staph get in through skin)
Skin/soft tissue infections (limited/resistance)

S. Pyogens - - Impetigo

25
Second Generation Cephalosporins - Common Agents: Spectrum Clinical uses
Cefoxitin (IV) Some GP coverage Increased Gram-negative activity Excellent anaerobe activity (rare to see with cephalosporins) Prophylaxis for intra-abdominal surgery · GI tract: want to include Gram – and anaerobes
26
Third Generation Cephalosporins - Common agents Spectrum which one covers pseudomonas ?
Ceftriaxone, IV (will see a lot) Ceftazidime, IV Excellent GN activity -- but NOT pseudomonas Ceftriaxone: · Community-acquired pneumonia, N. meningitis -- can penetrate the CSF · Many uses, serious infections Ceftazidime · Has activity against pseudomonas
27
4th Generation Cephalosporins - Common Agents - Resistances - Spectrum
Cefepime, IV only   Highly resistant b-lactamases   Broad spectrum · Gram-negative (excellent) – including pseudomonas · Gram-positive Serious or resistant infections
28
5th Generation Cephalosporins - Common agent - what is unique about its coverage ? - Clinical uses
Ceftaroline, IV Overcomes MRSA resistance, binds PBP2a Broad spectrum · Gram positive – only cephalosporin with MRSA activity · Gram negative – some, NOT pseudomonas
29
Beta Lactam: Carbapenem - Common Agents - Spectrum - what resistances are avoided
Imipenem Meropenem Ertapenem - Resistant to Beta Lactamases ``` VERY BROAD SPECTRUM · Gram negative, including pseudomonas · Gram-positive · Anaerobes Ertapenem – NO activity against Pseudomonas/Acinetobacter ``` Empiric treatment for serious infections Resistant infections
30
Beta Lactam: MonoBactams - Common Agents; - Spectrum - When is it used?
Aztreonam (IV) Spectrum: GN ONLY (including pseudomonas, but really a last resort) Clinical Uses: Only when there is allergy to other beta lactams
31
Glycopeptides: Common Agent Mechanism of Action - Mechanism of Resistance Bactericidal or Static ?
Vancomycin ``` Binds to terminal D-ala-D-ala (intermediate in cell wall synthesis) Inhibits transglycosylase (new chains) Inhibits transpeptidase (cross-links) ``` Alteration of binding site · VanA gene (D-ala D-lac can’t bind vancomycin) Bactericidal
32
Glycopeptide Common Adverse Events? Spectrum? Clinical Uses
Red Man Syndrome - Infusion reaction; Not Hypersensitivity Nephrotoxicity Spectrum: GP ONLY - Staph (including MRSA) - Sterp, Entero, C. diff GNs are intrinsically resistant Empiric therapy for severe infections C. Diff Infection
33
Cyclin Lipopeptides Common Agent Mechanism Bactericidal or Static
Daptomycin: IV Only Lipophilic tail inserts into cell membrane Membrane depolarization/K+ efflux Cessation of vital processes (i.e. ATP production) Cell death (without lysis) Bactericidal
34
Cyclin Lipopeptides: - Adverse Events - Spectrum - Clinical Uses
``` GI Distress: Headaches Elevated CPK/rhabodmyolysis · Associated with BID dosing · Clinical/lab monitoring Avoid statins ``` ``` Spectrum: - Gram-positive ONLY · Staphylococci (including MRSA) · Enterococci (including VRE) · GP anaerobes No gram-negative! ``` Clinical uses: Complicated Gram + infections · Skin/soft tissue · Bacteremia/endocarditis
35
Polymixins: | Common Agents:
Polymyxin B and Colistin Common Adverse Events: Nephrotoxicity; Neurotoxicity; Bronchospams Spectum: GN ONLY used for Pseudomonas Clinical Uses: Serious Resistant GN Infections Inhaled - resistant GN PNA
36
Bacitracin Fosfomycin
Bacitracin: Topical; GP only Fosfomycin: Oral, UTI only
37
What drugs are Anti-Pseudomonal?
Piperacillin+tazobactam 3rd generation Cephalosporins 4th Generation cephalosporins Ciprofloxacin Amonoglycosides: Gentimycin, Amikacin Polymixins -- monobactam: aztreonam
38
For what condition should you never use daptomycin? | why?
Never use daptomycin for PNA Daptomycin is inhibited by pulmonary surfactant
39
what are the best drugs for MSSA? po iv
po -Dicloxacillin, cephalexin iv - Nafcillin, Cefazolin
40
What are the best drugs for MRSA? iv po
iv - Linezolid, ceftaroline Vancomycin, Daptomycin -- high grade bacteremia, endovascular infections of bone/joint. ``` po - Clindamycin TMP/SMX Doxycyclin Linezolid ```